Fundraising Fox

Upstream Bio

NASDAQ: UPB

Waltham, US · Founded 2021 · Incorporated in Delaware · 84 employees on LinkedIn · 8 known investors

Upstream Bio is a biotechnology company that sponsors clinical trials to develop products under investigation. It works with clinical study staff, principal investigators, and healthcare practitioners at study sites conducting its trials.

BiotechHealthtech

Founders & leadership

RS
Rand SutherlandinChief Executive Officer
AAAllison Ambrose
Allison AmbroseinGeneral Counsel
ADAaron Deykin
Aaron DeykininChief Medical Officer & Head of R&D
MG
Mike GrayChief Financial Officer and Chief Operating Officer
AHAdam Houghton
Adam HoughtoninChief Business Officer
SP
Stacy PriceinChief Technology Officer

Investors · 8

OrbiMed✓ verifiedNew York · $1M – $75M
Access Industries✓ verifiedNew York
Access BiotechnologyNew York City
Bain Capital Life SciencesBoston
Decheng CapitalMenlo Park
Samsara BioCapitalPalo Alto
TCG CrossoverPalo Alto
Venrock Healthcare Capital PartnersreportedNew York

In the news

Upstream Bio (NASDAQ: UPB) reports Q2 2026 loss and advances Phase 3 plansstocktitan.net · Aug 2026Upstream Bio posts $80M loss, holds $261M cash | UPB Quarterly Report (10-Q)stocktitan.net · Aug 2026Upstream Bio, two other U.S. biotech startups price IPOs as healthcare listings rise | Reutersreuters.com · Oct 2024

Frequently asked questions

What does Upstream Bio do?
Upstream Bio is a biotechnology company that sponsors clinical trials to develop products under investigation. It works with clinical study staff, principal investigators, and healthcare practitioners at study sites conducting its trials.
Who are Upstream Bio's investors?
Upstream Bio's investors include OrbiMed, Access Industries, Access Biotechnology, Bain Capital Life Sciences, Decheng Capital, Samsara BioCapital, TCG Crossover, Venrock Healthcare Capital Partners.
Where is Upstream Bio headquartered?
Upstream Bio is headquartered in Waltham, US.